Targovax ASA logo

TRVX - Targovax ASA News Story

NOK7.8 -0.3  -3.1%

Last Trade - 3:25pm

Sector
Healthcare
Size
Small Cap
Market Cap £50.7m
Enterprise Value £47.7m
Revenue £234k
Position in Universe 979th / 1781

BRIEF-Targovax: Completion Of Safety Lead-In And Preliminary Immune Activation Data In ONCOS-102 Trial

Wed 7th February, 2018 6:04am
Feb 7 (Reuters) - TARGOVAX ASA  TRVX.OL : 
    * REG-TARGOVAX ANNOUNCES COMPLETION OF SAFETY LEAD-IN AND 
PRELIMINARY IMMUNE ACTIVATION DATA IN ONCOS-102 TRIAL IN 
MESOTHELIOMA 
    * DSMB HAVE RECOMMENDED THAT RANDOMIZED PART OF TRIAL CAN 
BE 
INITIATED 
 
Source text for Eikon:  ID:nGNE4FZ57x  
Further company coverage:  TRVX.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.